HLUKF Projected Dividend Yield
Ord/H. Lundbeck A/S (Denmark) ( OTCBB : HLUKF )H. Lundbeck develops, produces and markets drugs for treating diseases of the central nervous system. Products include antidepressants for the treatment of depression, panic disorder, and prevention of relapse/recurrence. Antipsychotic products for psychotic disorders; schizophrenia, anxiety, restlessness and insomnia; treatment of psychotic disorders; acute psychotic episodes, exacerbation of psychotic disorders. Co.'s products inclue Cipralex®/Lexapro® for the treatment of depression and anxiety; Ebixa® for the treatment of Alzheimer's disease; Azilect® for the treatment of Parkinson's disease; Xenazine®, Sabril®, Saphris® Sycrest®, Onfi, and other. 29 YEAR PERFORMANCE RESULTS |
HLUKF Dividend History Detail HLUKF Dividend News HLUKF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend Amount (DKK) |
2022 |
N/A |
N/A |
Mar 25, 2022 |
Mar 28, 2022 |
2.0000 |
2022 Total: |
2.0000 |
||||
2021 |
N/A |
N/A |
Mar 25, 2021 |
Mar 26, 2021 |
2.5000 |
2021 Total: |
2.5000 |
||||
2020 |
N/A |
N/A |
Mar 26, 2020 |
Mar 27, 2020 |
4.1000 |
2020 Total: |
4.1000 |
||||
2019 |
N/A |
N/A |
Mar 28, 2019 |
Mar 29, 2019 |
12.0000 |
2019 Total: |
12.0000 |